CGCollette S. Guy

Collette S. Guy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Collette S. Guy has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transfer learning enables discovery of sub-micromolar antibacterials for ESKAPE pathogens from ultra-large chemical spaces

    by Miguel García-Ortegón, Srijit Seal, Emily Geddes, Jenny L. Littler, Collette S. Guy, Jonathan Whiteside, Carl Rasmussen, Andreas Bender, Sergio Bacallado

    We introduce a transfer learning framework using deep graph neural networks (DGNNs) to identify antibacterials from ultra-large chemical libraries.


  • Open Access

    The deacetylase NagA mediates the remodeling and recycling of peptidoglycan-derived amino sugars in mycobacteria

    by Collette S. Guy, Charlotte Cooper, Magdalena Karlikowska, James Harrison, Albel Singh, Luis Steven Servín-González, Caroline A. Evans, Saskia E. Bakker, Andrew Bottrill, Apoorva Bhatt, et al.


  • Open Access

    Fluorinated trehalose analogues for cell surface engineering and imaging of Mycobacterium tuberculosis

    by Collette S. Guy, James A. Gott, Jonathan Ramírez-Cárdenas, Christopher de Wolf, Christopher M. Furze, Geoff West, Juan C. Muñoz-García, Jesus Angulo, Elizabeth Fullam

    The mycobacterial trehalose LpqY-SugABC ATP-binding cassette (ABC) transporter was hijacked to import fluorine-modified trehalose analogues to label cell-surface glycolipids and directly visualise the Mycobacterium tuberculosis pathogen by Focused Ion Beam (FIB) Secondary Ion Mass Spectrometry.


  • Open Access

    Fluorinated trehalose analogues for cell surface engineering and imaging of Mycobacterium tuberculosis

    by Collette S. Guy, James A. Gott, Jonathan Ramírez-Cárdenas, Christopher de Wolf, Christopher M. Furze, Geoff West, Juan C. Muñoz-García, Jesus Angulo, Elizabeth Fullam

    The sensitive, rapid and accurate diagnosis of Mycobacterium tuberculosis ( Mtb ) infection is a central challenge in controlling the global tuberculosis (TB) pandemic. Yet the detection of mycobacteria is often made difficult by the low sensitivity of current diagnostic tools, with over 3.6 million TB cases missed each year. To overcome these limitations there is an urgent need for next-generation TB diagnostic technologies. Here we report the use of a discrete panel of native 19 F-trehalose (F-Tre) analogues to label and directly visualise Mtb by exploiting the uptake of fluorine-modified trehalose analogues via the mycobacterial trehalose LpqY-SugABC ATP-binding cassette (ABC) importer. We discovered the extent of modified F-Tre uptake correlates with LpqY substrate recognition and characterisation of the interacting sites by saturation transfer difference NMR coupled with molecular dynamics provides a unique glimpse into the molecular basis of fluorine-modified trehalose import in Mtb . Lipid profiling demonstrated that F-Tre analogues modified at positions 2, 3 and 6 are incorporated into mycobacterial cell-surface trehalose-containing glycolipids. This rapid one-step labelling approach facilitates the direct visualisation of F-Tre-labelled Mtb by focused ion beam (FIB) secondary ion mass spectrometry (SIMS), enabling pathogen specific detection. Collectively, our findings highlight that F-Tre analogues have potential as tools to probe and unravel Mtb biology and can be exploited to detect and image TB.

  • Open Access

    Interrogation of the Pathogen Box reveals small molecule ligands against the mycobacterial trehalose transporter LpqY-SugABC

    by Anjana Radhakrishnan, Chelsea M. Brown, Collette S. Guy, Charlotte Cooper, Raul Pacheco-Gomez, Phillip J. Stansfeld, Elizabeth Fullam

    Tuberculosis, caused by Mycobacterium tuberculosis, claims ∼1.5 million lives annually. Effective chemotherapy is essential to control TB, however the emergence of drug-resistant strains of TB have seriously threatened global attempts to control and eradicate this deadly pathogen. Trehalose recycling via the LpqY-SugABC importer is essential for the virulence and survival of Mtb and inhibiting or hijacking this transport system is an attractive approach for the development of novel anti-tubercular and diagnostic agents. Therefore, we interrogated the drug-like compounds in the open-source Medicines for Malaria Pathogen Box and successfully identified seven compounds from the TB, kinetoplastids and reference compound disease sets that recognise LpqY. The molecules have diverse chemical scaffolds, are not specific trehalose analogues, and may be used as novel templates to facilitate the development of therapeutics that kill Mtb with a novel mechanism of action via the mycobacterial trehalose LpqY-SugABC transport system.


  • Open Access

    Imaging of antitubercular dimeric boronic acids at the mycobacterial cell surface by click-probe capture

    by Collette S. Guy, Ruben M. F. Tomás, Qiao Tang, Matthew I. Gibson, Elizabeth Fullam

    Dimeric boronic acids kill Mycobacterium tuberculosis (Mtb) by targeting mycobacterial specific extracellular glycans, removing the requirement for a therapeutic agent to permeate the complex cell envelope. Here we report the successful development and use of new ‘clickable’ boronic acid probes as a powerful method to enable the direct detection and visualisation of this unique class of cell-surface targeting antitubercular agents.


  • Open Access

    Plasmonic Detection of SARS-CoV-2 Spike Protein with Polymer-Stabilized Glycosylated Gold Nanorods

    by Panagiotis G. Georgiou, Collette S. Guy, Muhammad Hasan, Ashfaq Ahmad, Sarah-Jane Richards, Alexander N. Baker, Neer V. Thakkar, Marc Walker, Sarojini Pandey, Neil R. Anderson, et al.

    The COVID-19 pandemic has highlighted the need for innovative biosensing, diagnostic, and surveillance platforms. Here we report that glycosylated, polymer-stabilized, gold nanorods can bind the SARS-CoV-2 spike protein and show correlation to the presence of SARS-CoV-2 in primary COVID-19 clinical samples. Telechelic polymers were prepared by reversible addition–fragmentation chain-transfer polymerization, enabling the capture of 2,3-sialyllactose and immobilization onto gold nanorods. Control experiments with a panel of lectins and a galactosamine-terminated polymer confirmed the selective binding. The glycosylated rods were shown to give dose-dependent responses against recombinant truncated SARS-CoV-2 spike protein, and the responses were further correlated using primary patient swab samples. The essentiality of the anisotropic particles for reducing the background interference is demonstrated. This highlights the utility of polymer tethering of glycans for plasmonic biosensors of infection.


  • Open Access

    Glycan-Based Flow-Through Device for the Detection of SARS-COV-2

    by Alexander N. Baker, Sarah-Jane Richards, Sarojini Pandey, Collette S. Guy, Ashfaq Ahmad, Muhammad Hasan, Caroline I. Biggs, Panagiotis G. Georgiou, Alexander J. Zwetsloot, Anne Straube, et al.


  • Open Access

    Osmium–arene complexes with high potency towards Mycobacterium tuberculosis

    by James P C Coverdale, Collette S Guy, Hannah E Bridgewater, Russell J Needham, Elizabeth Fullam, Peter J Sadler

    The treatment of tuberculosis (TB) poses a major challenge as frontline therapeutic agents become increasingly ineffective with the emergence and spread of drug-resistant strains of Mycobacterium tuberculosis (Mtb). To combat this global health problem, new antitubercular agents with novel modes of action are needed. We have screened a close family of 17 organometallic half-sandwich Os(II) complexes [(arene)Os(phenyl-azo/imino-pyridine)(Cl/I)]+Y– containing various arenes (p-cymene, biphenyl, or terphenyl), and NMe2, F, Cl, or Br phenyl or pyridyl substituents, for activity towards Mtb in comparison with normal human lung cells (MRC5). In general, complexes with a monodentate iodido ligand were more potent than chlorido complexes, and the five most potent iodido complexes (MIC 1.25–2.5 µM) have an electron-donating Me2N or OH substituent on the phenyl ring. As expected, the counter anion Y (PF6–, Cl–, I–) had little effect on the activity. The pattern of potency of the complexes towards Mtb is similar to that towards human cells, perhaps because in both cases intracellular thiols are likely to be involved in their activation and their redox mechanism of action. The most active complex against Mtb is the p-cymene Os(II) NMe2-phenyl-azopyridine iodido complex (2), a relatively inert complex that also exhibits potent activity towards cancer cells. The uptake of Os from complex 2 by Mtb is rapid and peaks after 6 h, with temperature-dependence studies suggesting a major role for active transport. Significance to Metallomics Antimicrobial resistance is a global health problem. New advances are urgently needed in the discovery of new antibiotics with novel mechanisms of action. Half-sandwich organometallic complexes offer a versatile platform for drug design. We show that with an appropriate choice of the arene, an N,N-chelated ligand, and monodentate ligand, half-sandwich organo–osmium(II) complexes can exhibit potent activity towards Mycobacterium tuberculosis (Mtb), the leading cause of death from a single infectious agent. The patterns of activity of the 17 azo- and imino-pyridine complexes studied here towards Mtb and normal lung cells suggest a common redox mechanism of action involving intracellular thiols.


  • Correction to “The SARS-COV-2 Spike Protein Binds Sialic Acids, and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device”

    by Alexander Baker, Sarah-Jane Richards, Thomas Congdon, Muhammad Hasan, Collette Guy, Alexander Zwetsloot, Angelo Gallo, Józef Lewandowski, Phillip Stansfeld, Anne Straube, et al.